PSMA-targeted contrast agents for intraoperative imaging of prostate cancer

Chem Commun (Camb). 2017 Feb 4;53(10):1611-1614. doi: 10.1039/c6cc09781b. Epub 2017 Jan 13.

Abstract

Prostate-specific membrane antigen (PSMA) can serve as a molecular cell surface target for the detection and treatment of prostate cancer. Near-infrared (NIR) fluorescence imaging enables highly sensitive, rapid, and non-radioactive imaging of PSMA, though specific targeting still remains a challenge because no optimized contrast agents exist.

MeSH terms

  • Animals
  • Antigens, Surface / analysis*
  • Contrast Media / analysis*
  • Contrast Media / chemistry
  • Glutamate Carboxypeptidase II / analysis*
  • Humans
  • Male
  • Mice
  • Molecular Structure
  • Neoplasms, Experimental / diagnostic imaging
  • Optical Imaging*
  • Prostatic Neoplasms / diagnostic imaging*

Substances

  • Antigens, Surface
  • Contrast Media
  • FOLH1 protein, human
  • Glutamate Carboxypeptidase II